MBF-015

· Medibiofarma S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBF-015, covering 2025-03-03 to 2025-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients [Phase 2]

See pricing